Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs IVZ✓SelectedUSD · IVZMRNA vs IVZ performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs IVZ

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
IVZ return
+34.5%
Excess return
-65.5%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioIVZExcessAlpha
1D-2.2%-4.5%+2.4%+0.4%
7D-12.7%-8.3%-4.4%-8.3%
30D-20.7%-8.7%-12.0%-16.3%
3M+46.3%-14.8%+61.1%+60.1%
6M+305.2%-0.3%+305.6%+303.0%
YTD+561.2%+4.0%+557.2%+539.3%
1Y+772.1%+20.3%+751.7%+678.9%
3Y+147.0%+114.9%+32.1%+54.0%
All-31.0%+34.5%-65.5%-50.3%

Cumulative growth

Daily Returns

Daily percentage return beside IVZ.

Daily Out/Under-Performance

Portfolio return minus IVZ return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling